Distribution date: 12 April 2022 | Final date for Comment: 06 May 2025

This normative instruction contains provisions on Good Manufacturing Practices complementary to Blood-derived Medicines.

Products Covered: HS (3003-3004) - Medicaments

Regulation Type: Regular notification

Distribution date: 12 April 2022 | Final date for Comment: 06 May 2025

This normative instruction contains provisions on Good Manufacturing Practices complementary to Blood-derived Medicines.

Products Covered: HS (3003-3004) - Medicaments

Regulation Type: Regular notification

Distribution date: 12 April 2022 | Final date for Comment: 06 May 2025

This resolution contains provision on the obligation of all companies established in the country, which carry out the activities of manufacturing, importing, exporting, fractionating, storing, dispatching and distributing active pharmaceutical ingredients, to register, with Anvisa, all active pharmaceutical ingredients with which they work.

Products Covered: HS (3006) - Active Pharmaceutical Ingredients

Regulation Type: Regular notification

Distribution date: 12 April 2022 | Final date for Comment: 06 May 2025

This resolution contains provision on the obligation of all companies established in the country, which carry out the activities of manufacturing, importing, exporting, fractionating, storing, dispatching and distributing active pharmaceutical ingredients, to register, with Anvisa, all active pharmaceutical ingredients with which they work.

Products Covered: HS (3006) - Active Pharmaceutical Ingredients

Regulation Type: Regular notification

Distribution date: 12 April 2022 | Final date for Comment: 06 May 2025

This normative instruction contains provisions on Good Manufacturing Practices complementary to the reference and retention samples.

Products Covered: HS (3003-3004) - Medicaments

Regulation Type: Regular notification

Distribution date: 12 April 2022 | Final date for Comment: 06 May 2025

This normative instruction contains provisions on Good Manufacturing Practices complementary to the reference and retention samples.

Products Covered: HS (3003-3004) - Medicaments

Regulation Type: Regular notification

Distribution date: 12 April 2022 | Final date for Comment: 06 May 2025

This resolution contains provisions on the framing of menthol-containing products such as medicines, medical devices or personal hygiene products, cosmetics and perfumes.

Products Covered: HS (3003, 3004, 3006,3303, 3304, 3305, 3306, 3307) – Medicaments, medical devices, toiletries, cosmetics and perfumes

Regulation Type: Regular notification

Distribution date: 12 April 2022 | Final date for Comment: 06 May 2025

This resolution contains provisions on the framing of menthol-containing products such as medicines, medical devices or personal hygiene products, cosmetics and perfumes.

Products Covered: HS (3003, 3004, 3006,3303, 3304, 3305, 3306, 3307) – Medicaments, medical devices, toiletries, cosmetics and perfumes

Regulation Type: Regular notification

Distribution date: 12 April 2022 | Final date for Comment: 06 May 2025

This normative instruction contains provisions on Good Manufacturing Practices complementary to Herbal Medicinal products.

Products Covered: HS (3003-3004) - Herbal medicinal products

Regulation Type: Regular notification

Distribution date: 12 April 2022 | Final date for Comment: 06 May 2025

This normative instruction contains provisions on Good Manufacturing Practices complementary to Herbal Medicinal products.

Products Covered: HS (3003-3004) - Herbal medicinal products

Regulation Type: Regular notification